Acquisition of suppressive function by conventional T cells limits antitumor immunity upon Treg depletion.
Ontology highlight
ABSTRACT: Regulatory T (Treg) cells contribute to immune homeostasis but suppress immune responses to cancer. Strategies to disrupt Treg cell-mediated cancer immunosuppression have been met with limited clinical success, but the underlying mechanisms for treatment failure are poorly understood. By modeling Treg cell-targeted immunotherapy in mice, we find that CD4+ Foxp3- conventional T (Tconv) cells acquire suppressive function upon depletion of Foxp3+ Treg cells, limiting therapeutic efficacy. Foxp3- Tconv cells within tumors adopt a Treg cell-like transcriptional profile upon ablation of Treg cells and acquire the ability to suppress T cell activation and proliferati
SUBMITTER: Whiteside SK
PROVIDER: S-EPMC7615475 | biostudies-literature | 2023 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA